Dr. Anand Rajendran

Prof & Head Retina Service, Aravind Eye Hospital, Chennai

1 article

Anand Rajendran, FRCS, DNB, is a Professor of Ophthalmology and Head of the VitreoRetinal Service at Aravind Eye Hospital, Chennai. He was the Convener, Scientific Committee of VitreoRetinal Society of India (VRSI) 9 2019-2021 and the Chief Editor of VRSI National Newsletter. He obtained his medical degree from the Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry. He did his Ophthalmology residency and retina fellowship at Aravind Eye Hospital, Madurai. He is a Fellow of the Royal College of Physicians and Surgeons (Glasgow). He has trained at the Bascom-Palmer Eye Institute in Miami with Dr.Phil Rosenfeld, The Doheny Eye Institute, Los Angeles with Dr.Srinivas Sadda, and at the Vitreo-Retina Macula Clinic of New York with Dr. Lawrence Yannuzzi and Dr.Rick Spaide. He has been on the Scientific committee responsible for setting up the Scientific Programme for The Annual Meet of the VRSI twice (2015-2016). He is an active board member of various international retinal conglomerates like Retina World Congress. SOLS ( Subthreshold Ophthalmic Laser Society), Vit-Buckle Society, FRB! (Fighting Retinal Blindness) He has a particular interest in anti-VEGF therapy, macular diseases , retinal vascular disorders and surgical retina. He has several publications in national and international journals and 8 textbook chapters. He has made numerous presentations at international and national meets and has been a Principal Investigator and Co-Investigator for various International Clinical Trials.

  1. Articles 13 Jun 2022 7 min read

    Ten Pearls for Managing A case of Proliferative Diabetic Retinopathy

    Diabetes has reached epidemic proportions in many developing economies, such as China and India. Type 2 DM contributes to 90% of the cases. An astonishing 53 % of these cases remain undiagnosed(1). Health-seeking behaviour in India is amongst the poorest with 90% of patients being not aware of the need for regular fundus examination(2). The onus of imparting knowledge on such patients lies with the primary health care provider at the time of diagnosis. It is also the prime duty of the patient to gain knowledge about the disease. Catch them early Advice on the need for regular fundus examination should be given during the time of diagnosis. For type 2 diabetes, screening guidelines are fundus examination at the time of diagnosis and thereafter yearly, mild NPDR - yearly, moderate NPDR - 6 monthly, severe NPDR - 3 monthly follow up are mandatory. High resolution fundus images can be used for follow-up and patient education. Deep learning, a state-of-the-art machine learning technique is

    Dr. Indu Govindaraj · Dr. Anand Rajendran